Clinical Trial Update: Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating apatinib in combination with second-line chemotherapy for metastatic colorectal cancer, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Liqiang Zhong | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN